Reference priceRUB ₽57,750.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Polivy VL |
|---|---|
| Manufacturer | GENENTECH USA |
| Prescription required | Yes |
Polivy VL 140mg(polatuzumab vedotin-piiq)
polatuzumab vedotin-piiq
Description
Polivy VL 140mg(polatuzumab vedotin-piiq) is a medicine catalog record in the MediPriceHub database. Active ingredient: polatuzumab vedotin-piiq. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: GENENTECH USA. Therapeutic category: Medicine Library > Oncology Medicines > Lymphoma medication. Pack information: 140. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
POLIVY is a CD79b-directed antibody and microtubule inhibitor conjugate indicated: in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an International Prognostic Index score of 2 or greater. in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory DLBCL, NOS, after at least two prior therapies.How to Use
Use polatuzumab vedotin-piiq under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: polatuzumab vedotin-piiq. Pack size: 140. Pack unit: bottle. Manufacturer: GENENTECH USA. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Lymphoma medication. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Эта информация носит справочный характер. Перед применением лекарства проконсультируйтесь с медицинским специалистом.